MAPT and neurodevelopmental disorder: In addition to SRRM2 and PNN, we tested SETD1A—a histone methyltransferase implicated in neurodevelopmental disorders that contains 24 consecutive serines—and observed enrichment in tau aggregates (SI Appendix, Fig. S1D).